Sayed Dawood, Salmon John, Khan Talal W, Sack Andrew M, Braun Ted, Barnard Adele, Rotte Anand
University of Kansas School of Medicine, Kansas City, KS, USA.
PainCare Perth, Parkland House, Cottesloe, Western Australia, Australia.
J Pain Res. 2020 Jun 15;13:1441-1448. doi: 10.2147/JPR.S257071. eCollection 2020.
Patients living with chronic upper limb and neck (ULN) pain are reliant on often ineffective therapies as they face limited options for effective long-term treatment.
Prospective clinical studies have demonstrated that high-frequency spinal cord stimulation at 10 kHz (10 kHz SCS) is effective in treating chronic pain in multiple etiologies including ULN pain. This study aimed at validating the findings from clinical studies on ULN in a real-world cohort.
A retrospective, observational review.
A multicenter review between April 2016 and August 2019.
Anonymized data were extracted from a real-world database of 47 consecutive patients aged ≥18 years of age with chronic upper limb and/or neck pain who were trialed and permanently implanted with 10 kHz SCS. Patient-reported pain relief, quality of life, function, sleep and medication use were extracted from anonymised patient records where available. Responder rates, defined as the proportion of patients with at least 50% pain relief at the end of trial and the last visit after implantation, were calculated.
All patients reported successful response (≥50% pain relief) at the end of trial and >75% patients continued to respond to the therapy at the last follow-up period. Majority (72%) of patients reported improvement in function, about half of the patients (53%) reported improvement in sleep and one-third of the patients (36%) reported reducing their medication at last follow-up.
10 kHz SCS provides durable pain relief to patients with chronic upper limb and neck pain.
患有慢性上肢和颈部(ULN)疼痛的患者依赖于往往无效的治疗方法,因为他们面临的有效长期治疗选择有限。
前瞻性临床研究表明,10kHz高频脊髓刺激(10kHz SCS)在治疗包括ULN疼痛在内的多种病因引起的慢性疼痛方面是有效的。本研究旨在在真实世界队列中验证关于ULN的临床研究结果。
一项回顾性观察性综述。
2016年4月至2019年8月期间的多中心综述。
从一个真实世界数据库中提取匿名数据,该数据库包含47名年龄≥18岁、患有慢性上肢和/或颈部疼痛的连续患者,这些患者接受了10kHz SCS试验并永久植入。在可用的情况下,从匿名患者记录中提取患者报告的疼痛缓解情况、生活质量、功能、睡眠和药物使用情况。计算反应率,定义为在试验结束时和植入后最后一次随访时疼痛缓解至少50%的患者比例。
所有患者在试验结束时均报告有成功反应(疼痛缓解≥50%),超过75%的患者在最后随访期继续对该治疗有反应。大多数(72%)患者报告功能有所改善,约一半(53%)的患者报告睡眠有所改善,三分之一(36%)的患者报告在最后随访时减少了药物使用。
10kHz SCS为慢性上肢和颈部疼痛患者提供持久的疼痛缓解。